NCT06702852 is a NA clinical trial of NIRS imaging in addition to SOC in Ulcers, sponsored by Kent Imaging Inc.

Who is sponsoring NCT06702852?

NCT06702852 is sponsored by Kent Imaging Inc.

What drugs are being tested in NCT06702852?

Interventions in NCT06702852: NIRS imaging in addition to SOC.

Is NCT06702852 still recruiting?

NCT06702852 is currently terminated. Last updated 23 May 2025.

Last reviewed 2025-05-23 · How we verify

NCT06702852

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Effect of NIRS-assisted Assessment on Chronic Lower Extremity and Other Chronic Non-healing Ulcers

Terminated NA Last updated 23 May 2025

What this trial tests

NA trial testing NIRS imaging in addition to SOC in Ulcers in 221 participants. Terminated before completion.

Timeline

22 July 2024

Primary endpoint
31 January 2025

25 February 2025

Quick facts

Lead sponsor	Kent Imaging Inc
Phase	NA
Status	Terminated
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	other
Enrollment	221
Start date	22 July 2024
Primary completion	31 January 2025
Estimated completion	25 February 2025
Sites	4 locations across United States

Drugs / interventions tested

NIRS imaging in addition to SOC

Conditions studied

Ulcers — all drugs for Ulcers →

Sponsor

Kent Imaging Inc

Who can join

18 and older, any sex, with Ulcers. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Investigation of the predictive value of Near Infrared Spectroscopy in Chronic Lower Extremity and Other Chronic non-healing Ulcers

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Ulcers

Currently open trials in the same condition.

NCT07079774 — TrueLok Elevate PMCF Study · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06702852 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Kent Imaging Inc
Last refreshed: 23 May 2025

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06702852.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing